Glaxo Smith Kline 58160097620 Bexsero Meningitis Vaccine Indicated for People 10 Through 25 Years of Age Meningococcal Group B Vaccine 50 mcg - 50 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL

BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
BEXSERO is approved for use in individuals 10 through 25 years of age
BEXSERO is supplied as a 0.5 mL suspension in a glass pre-filled syringe
10 Syringes

Manufacturer # 58160097620
Brand Bexsero®
Manufacturer Glaxo Smith Kline
Country of Origin Unknown
Application Meningitis Vaccine
Container Type Prefilled Syringe
Dosage Form Injection
Generic Drug Code 35944
Generic Drug Name Meningococcal Group B Vaccine
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag Y
NDC Number 58160097620
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Strength 50 mcg - 50 mcg / 0.5 mL
Supplier_ID 488095
Type Intramuscular
UNSPSC Code 51201610
User Indicated for People 10 Through 25 Years of Age
Volume 0.5 mL